{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:52:45Z","timestamp":1793645565588,"version":"4.5.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biopha.2023.115583","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:33:42Z","timestamp":1695774822000},"page":"115583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Passive immunization with anti-FimA egg yolk antibodies (IgYs) mitigate Acinetobacter baumannii pneumonia in mice"],"prefix":"10.1016","volume":"167","author":[{"given":"Nasibeh","family":"Shaygankho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Jahangiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0530-4324","authenticated-orcid":false,"given":"Iraj","family":"Rasooli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115583_bib1","article-title":"Promising targets for immunotherapeutic approaches against Acinetobacter baumannii","author":"de Freitas","year":"2022","journal-title":"Microb. Pathog."},{"issue":"3","key":"10.1016\/j.biopha.2023.115583_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/14760584.2021.1887735","article-title":"Where are we and how far is there to go in the development of an Acinetobacter vaccine?","volume":"20","author":"Ma","year":"2021","journal-title":"Expert Rev. Vaccin."},{"issue":"3","key":"10.1016\/j.biopha.2023.115583_bib3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biopha.2023.115583_bib4","first-page":"120","article-title":"Non-antibiotic prevention and treatment against Acinetobacter baumannii infection: are vaccines and adjuvants effective strategies?","volume":"14","author":"Hu","year":"2023","journal-title":"Front. Microbiol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115583_bib5","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3390\/pathogens10081006","article-title":"Acinetobacter baumannii infections in times of COVID-19 pandemic","volume":"10","author":"Rangel","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.biopha.2023.115583_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.procbio.2023.05.032","article-title":"Egg-yolk antibodies raised to VacJ passively immunize mice against Acinetobacter baumannii pneumonia in a neutropenic murine model","author":"Sharifi","year":"2023","journal-title":"Process Biochem."},{"key":"10.1016\/j.biopha.2023.115583_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.molimm.2022.06.010","article-title":"Immunoprotective characterization of egg yolk immunoglobulin raised to loop 3 of outer membrane protein 34 (Omp34) in a murine model against Acinetobacter baumannii","volume":"149","author":"Moghaddam","year":"2022","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115583_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-81356-8","article-title":"Specific egg yolk immunoglobulin as a promising non-antibiotic biotherapeutic product against Acinetobacter baumannii pneumonia infection","volume":"11","author":"Jahangiri","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2023.115583_bib9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/jam.14135","article-title":"Specific egg yolk antibodies (IgY) confer protection against Acinetobacter baumannii in a murine pneumonia model","volume":"126","author":"Jahangiri","year":"2019","journal-title":"J. Appl. Microbiol"},{"issue":"1","key":"10.1016\/j.biopha.2023.115583_bib10","doi-asserted-by":"crossref","first-page":"12576","DOI":"10.1038\/s41598-022-16894-w","article-title":"Specific egg yolk antibody raised to biofilm associated protein (Bap) is protective against murine pneumonia caused by Acinetobacter baumannii","volume":"12","author":"Ranjbar","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115583_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106269","article-title":"IgY-technology (egg yolk antibodies) in human medicine: a review of patents and clinical trials","volume":"81","author":"Leiva","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115583_bib12","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ppul.20875","article-title":"Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients","volume":"43","author":"Nilsson","year":"2008","journal-title":"Pediatr. Pulmonol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115583_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ppul.10290","article-title":"Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: a phase I feasibility study","volume":"35","author":"Kollberg","year":"2003","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.biopha.2023.115583_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.899617","article-title":"Egg-derived anti-SARS-CoV-2 immunoglobulin Y (IgY) with broad variant activity as intranasal prophylaxis against COVID-19","volume":"13","author":"Frumkin","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.115583_bib15","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.2147\/IDR.S332051","article-title":"Acinetobacter baumannii biofilm formation and its role in disease pathogenesis: a review","author":"Gedefie","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.biopha.2023.115583_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2021.126722","article-title":"An overview of Acinetobacter baumannii pathogenesis: motility, adherence and biofilm formation","volume":"247","author":"Mea","year":"2021","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.biopha.2023.115583_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.676458","article-title":"Bacterial biofilm inhibition: a focused review on recent therapeutic strategies for combating the biofilm mediated infections","volume":"12","author":"Srinivasan","year":"2021","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115583_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077631","article-title":"Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii","volume":"8","author":"Moriel","year":"2013","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.biopha.2023.115583_bib19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/apm.13061","article-title":"Prevention of nosocomial Acinetobacter baumannii infections with a conserved immunogenic fimbrial protein","volume":"128","author":"Mahmoudi","year":"2020","journal-title":"APMIS"},{"issue":"34","key":"10.1016\/j.biopha.2023.115583_bib20","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1016\/j.vaccine.2020.06.052","article-title":"Type I pili, CsuA\/B and FimA induce a protective immune response against Acinetobacter baumannii","volume":"38","author":"Ramezanalizadeh","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biopha.2023.115583_bib21","doi-asserted-by":"crossref","first-page":"19909","DOI":"10.1038\/s41598-022-24163-z","article-title":"Vaccination with a combination of planktonic and biofilm virulence factors confers protection against carbapenem-resistant Acinetobacter baumannii strains","volume":"12","author":"Ramezanalizadeh","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2023.115583_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/01480548309072465","article-title":"Estimating LD50 using the probit technique: a basic computer program","volume":"6","author":"Lieberman","year":"1983","journal-title":"Drug Chem. Toxicol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115583_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260627","article-title":"Mouse pneumonia model by Acinetobacter baumannii multidrug resistant strains: comparison between intranasal inoculation, intratracheal instillation and oropharyngeal aspiration techniques","volume":"16","author":"Bergamini","year":"2021","journal-title":"PLOS ONE"},{"issue":"3","key":"10.1016\/j.biopha.2023.115583_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/ilar.46.3.269","article-title":"Critical steps in the production of polyclonal and monoclonal antibodies: evaluation and recommendations","volume":"46","author":"Leenaars","year":"2005","journal-title":"ILAR J."},{"key":"10.1016\/j.biopha.2023.115583_bib25","first-page":"1","article-title":"Acinetobacter baumannii subunit vaccines: recent progress and challenges","author":"Lau","year":"2023","journal-title":"Crit. Rev. Microbiol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:16:05Z","timestamp":1776460565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223013811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":25,"alternative-id":["S0753332223013811"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115583","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Passive immunization with anti-FimA egg yolk antibodies (IgYs) mitigate Acinetobacter baumannii pneumonia in mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115583"}}